In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Late-breaking trials articles published at EuroPCR 2018 and PCR Trials book

As always, EuroPCR is the place to be for keeping up-to-date with innovation! Discover all of the pioneering studies that have been presented during the dedicated Hotline & Late-breaking trial sessions.



Late breaking trials articles published at EuroPCR 2018

  • Joanna WYKRZYKOWSKA / Complete 2-year results of the Amsterdam-investigator-initiated-Absorb strategy all-comers trial / May 22d - 16:25
  • Philip URBAN / Biolimus-A9 polymer-free coated stent in high bleeding risk patients undergoing complex PCI - evidence from the Leaders Free randomised clinical trial / May 23d - 10:30
  • Marlies KOK / BIO-RESORT: two-year outcome of the three-arm randomised trial in 3 514 all-comer patients, treated with highly dissimilar contemporary DES / May 23d - 10:30
  • Ziad ALI / Validation of a novel non-hyperemic index of coronary artery stenosis severity - the Resting Full-cycle Ratio (RFR) - VALIDATE RFR / May 23d - 11:36
  • Shigeru SAITO / Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: Final 5-year results of the CENTURY II (Clinical Evaluation of New Terumo Drug- Eluting Coronary Stent System in the Treatment of Patients with Drug- Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) randomized clinical trial / May 23d - 11:40
  • Elmir OMEROVIC / Bioabsorbable Polymer Everolimus-Eluting Stents in Patients with Acute Myocardial Infarction: A report from the Swedish Cororary Angiography and Angioplasty Registry / May 24th - 10:52
  • Giovanni DE MARIA / Index of microcirculatory resistance-guided therapy with pressure control intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in STEMI: the OXAMI-PICSO study / May 24th - 11:03
  • David FOLEY / Celtic bifurcation / May 24th - 11:25

PCR Trials book

Publication of the updated print and digital editions with 5 new trials:   

  • PIONEER AF-PCI (Rivaroxaban vs standard treatment in patients with atrial fibrillation undergoing PCI)
  • RE-DUAL PCI (Antiplatelet (Dabigatran versus Vitamin K antagonists in patients with atrial fibrillation and PCI)
  • SECURE-PCI (Atorvastatin prior to PCI in acute coronary syndromes)
  • SMART-DATE (6 month vs 12 month or longer DAPT after PCI for ACS)
  • TWENTE II 5 years (Zotarolimus-eluting vs.Everolimus-eluting Stents)

Find out more